Vaccinex, Inc.

Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, and neurodegenerative diseases, with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. The company is also leveraging its proprietary drug…More discovery platform, ActivMAb®, to create opportunities for future pipeline expansion and strategic collaborations, particularly for development of high value antibodies to multi-pass membrane receptors. Vaccinex is based in Rochester, New York.